| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/01/2008 | CA2356240C Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
| 04/01/2008 | CA2356157C Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| 04/01/2008 | CA2343299C Method for preventing or delaying catheter-based revascularization |
| 04/01/2008 | CA2294099C Absorption of minerals |
| 03/27/2008 | WO2008036715A1 Heterocyclic organic compounds |
| 03/27/2008 | WO2008036286A1 Crystalline rosuvastatin calcium |
| 03/27/2008 | WO2008035823A1 Cell death inhibitor |
| 03/27/2008 | WO2008035757A1 Jelly-like food containing ubiquinol |
| 03/27/2008 | WO2008035686A1 Agent for improving insulin resistance |
| 03/27/2008 | WO2008035583A1 Moisturizing agent, cell-activating agent, antioxidant agent, protease activity enhancing agent, anti-aging agent, skin-whitening agent, anti-inflammatory agent, and neutral fat accumulation-inhibiting agent |
| 03/27/2008 | WO2008035359A2 Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
| 03/27/2008 | WO2008035023A1 Polymorphs of rimonabant |
| 03/27/2008 | WO2008034989A2 Use of quinoa extract as cosmetic and pharmaceutic slimming agent and/or as an agent preventing the formation of new fats in the human body |
| 03/27/2008 | WO2008034832A1 Compositions comprising a statin and caffeine for the treatment of viral infection |
| 03/27/2008 | WO2008034815A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | WO2008034533A1 Compositions containing inhibitors of gastro-intestinal lipase |
| 03/27/2008 | WO2008034238A1 Methods for producing pure amino acid chelate complexes, and uses thereof |
| 03/27/2008 | WO2008002655A3 Crystalline forms of atorvastatin |
| 03/27/2008 | WO2008000070B1 Glycyrrhetinic acid derivatives |
| 03/27/2008 | WO2007141200A8 Novel n-aryl and n-heteroaryl substituted pyridinone derivatives for use in mch-1 mediated diseases |
| 03/27/2008 | WO2007128480A3 Thioglycosides as pharmaceutically active agents |
| 03/27/2008 | WO2007084314A3 MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 03/27/2008 | WO2007045663A3 Combination of an ati receptor antagonist and a np inhibitor fro treating ia hypertension and heartfailure |
| 03/27/2008 | US20080076819 Treating non-insulin dependent diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome; 6-[(1-cycloheptyl-4,4-dimethyl-5-oxopyrrolidin-3-yl)methoxy]nicotinonitrile for example |
| 03/27/2008 | US20080076818 Novel processes for the preparation of dpp iv inhibitors |
| 03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
| 03/27/2008 | US20080076814 Hexahydro-Cyclooctyl Pyrazole Cannabinoid Modulators |
| 03/27/2008 | US20080076811 Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents |
| 03/27/2008 | US20080076810 Benzoureas Having Anti-Diabetic Activity |
| 03/27/2008 | US20080076804 Methods for inhibiting and breaking age complex formation |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076778 PARP (poly-ADP ribose polymerase); drug screening; computer networks |
| 03/27/2008 | US20080076775 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 03/27/2008 | US20080076773 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt |
| 03/27/2008 | US20080076768 Pharmaceutical compounds |
| 03/27/2008 | US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors |
| 03/27/2008 | US20080076751 Azetidinone Derivatives and Methods of Use Thereof |
| 03/27/2008 | US20080076750 Azetidinone Derivatives and Methods of Use Thereof |
| 03/27/2008 | US20080076714 oral or mucosal administration for treating immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease and other inflammatory diseases; drug delivery method |
| 03/27/2008 | US20080076705 Antidiabetic agents; genetic engineered polypeptide; having a side chain attached alpha -amino group of the N-terminal amino acid of the B chain via an amide bond, with free carboxylic acid group, a fatty acid; soluble at physiological pH, prolonged profile of action; hypoglycemic agents |
| 03/27/2008 | US20080075799 Use Of Medicinal Plants And Extracts Thereof With Growth Promoting Activity In Veterinary Medicine And Zootechnics |
| 03/27/2008 | US20080075782 Comprising a stabilizing polyol and a bioactive agent, wherein the composition provides quick release of the bioactive agent after administration; inhalation through the mouth; drug delivery; osteoporosis treatment |
| 03/27/2008 | US20080075731 nanoparticle comprising a core made of a metal or polyoxyethylene glycol coatings, binding to core with lipoprotein binding agent, 7-alpha hydroxylase or antibody, and nicotinamide adenine dinucleotide; drug delivery particles; using a magnet to administer nanoparticles to target anatomical site |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075664 Control Of Diabetes And Obesity |
| 03/27/2008 | DE102006044448A1 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 03/27/2008 | DE102006041905A1 Zubereitungen zur oralen Aufnahme (I) Preparations for oral ingestion (I) |
| 03/27/2008 | DE102006021874B4 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, process for their preparation and their use as medicaments |
| 03/27/2008 | CA2700360A1 In vivo transformation of pancreatic acinar cells into insulin-producing cells |
| 03/27/2008 | CA2666649A1 Insulin resistance improving agent |
| 03/27/2008 | CA2663901A1 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 03/27/2008 | CA2663697A1 Use of quinoa extract as cosmetic and pharmaceutic slimming agent and/or as an agent preventing the formation of new fats in the human body |
| 03/27/2008 | CA2663269A1 Combination of nmda-receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | CA2662613A1 Compositions and methods relating to glucagon receptor antibodies |
| 03/27/2008 | CA2662574A1 Heterocyclic organic compounds |
| 03/27/2008 | CA2646909A1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 03/27/2008 | CA2645185A1 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903043A1 Novel pharmaceutical |
| 03/26/2008 | EP1902733A1 Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity |
| 03/26/2008 | EP1902723A1 Medicament comprising an extract from capsicum, garlic and/or sabal as lipase inhibitor |
| 03/26/2008 | EP1902722A1 Agent for elevating adiponectin concentration |
| 03/26/2008 | EP1902713A1 Pharmaceutical composition containing thiazolidinedione compound |
| 03/26/2008 | EP1902710A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 03/26/2008 | EP1902052A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
| 03/26/2008 | EP1902041A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer s desease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 03/26/2008 | EP1902039A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 03/26/2008 | EP1902032A1 Pharmaceutical compounds |
| 03/26/2008 | EP1902028A2 Histamine h3 receptor antagonists |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1696924B1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/26/2008 | EP1638586B1 A synergistic composition for the treatment of diabetes mellitus |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | EP1465911B1 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 03/26/2008 | EP1462439B1 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP1229918B1 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 03/26/2008 | CN101151267A Chemical compounds |
| 03/26/2008 | CN101151260A Benzimidazole derivative and use as angiotensin ii antagonist |
| 03/26/2008 | CN101151245A Indan-amide derivatives with glycogen phosphorylase inhibitory activity |
| 03/26/2008 | CN101151244A Histamine H3 receptor agents, preparation and therapeutic uses |
| 03/26/2008 | CN101151042A Medicament consisting of plant extracts as a lipase inhibitor |
| 03/26/2008 | CN101151036A Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| 03/26/2008 | CN101151027A Combination of organic compounds |
| 03/26/2008 | CN101148473A Recombination human insulin and its coding gene and application |
| 03/26/2008 | CN101147807A Substances for preventing and treating autoimmune diseases |
| 03/26/2008 | CN101147806A Berberine intestinal controlled-releasing microcapsule and its preparation method |
| 03/26/2008 | CN101147780A Medicine for treating hypertension and hyperlipemia and its preparing process |
| 03/26/2008 | CN101147758A Medicine for treating stomach disease and replenishing calcium and its preparation method |
| 03/26/2008 | CN101147749A Divaricate velvetplant medicinal preparation for treating diabetes |
| 03/26/2008 | CN101147736A Composition capable of reducing blood lipoid and lowering cholesterol |
| 03/26/2008 | CN101147730A Constitution of xylitol tablet containing selenium and vitamin E and manufacturing method thereof |
| 03/26/2008 | CN101147587A Calcium-phosphorus mixture and its use |
| 03/26/2008 | CN101147584A Health-care food capable of preventing and treating diabetes and preparation method thereof |
| 03/26/2008 | CN101147524A Xylitol chewing gum containing compound medicine and food dual-purpose preparation and its preparation technique |
| 03/26/2008 | CN100376592C Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |